BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 18475247)

  • 1. Thromboembolic prophylaxis in head trauma and multiple-trauma patients.
    Latronico N; Berardino M
    Minerva Anestesiol; 2008 Oct; 74(10):543-8. PubMed ID: 18475247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of venous thromboembolism.
    Pini M; Spyropoulos AC
    Semin Thromb Hemost; 2006 Nov; 32(8):755-66. PubMed ID: 17171588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of thromboprophylaxis management in patients with major trauma.
    Imberti D; Ageno W
    Pathophysiol Haemost Thromb; 2005; 34(6):249-54. PubMed ID: 16772735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative venous thromboembolism prophylaxis in Israel: a survey of academic surgical departments.
    Ellis MH; Elis A
    Eur J Haematol; 2004 Aug; 73(2):104-8. PubMed ID: 15245509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?
    Koya MP; Manoharan M; Kim SS; Soloway MS
    BJU Int; 2005 Nov; 96(7):1019-21. PubMed ID: 16225520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
    Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
    Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients.
    Cothren CC; Smith WR; Moore EE; Morgan SJ
    World J Surg; 2007 Jan; 31(1):98-104. PubMed ID: 17180563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venous thromboembolism prophylaxis with low molecular weight heparins in polytraumatized patients in intensive care unit (extended serie)].
    Kurtoğlu M; Büyükkurt CD; Kurtoğlu M; Dural CA; Güloğlu R; Akar U
    Ulus Travma Acil Cerrahi Derg; 2003 Jan; 9(1):37-44. PubMed ID: 12587053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rationale for long-term prophylaxis of venous thromboembolism.
    Agnelli G; Mancini GB; Biagini D
    Orthopedics; 2000 Jun; 23(6 Suppl):s643-6. PubMed ID: 10875429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis strategies for patients with acute venous thromboembolism.
    Tapson VF
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S524-31; discussion S531-4. PubMed ID: 11732663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.